Format

Send to

Choose Destination
J Med Ultrason (2001). 2018 Oct;45(4):605-610. doi: 10.1007/s10396-018-0880-3. Epub 2018 May 23.

Increased nitroglycerin-mediated vasodilation in migraineurs without aura in the interictal period.

Author information

1
Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. fujioka.kazumi@nihon-u.ac.jp.
2
Department of Internal Medicine, Izutobu General Hospital, Shizuoka, Japan.
3
Fujioka Dermatological Clinic, Tokyo, Japan.
4
Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

Abstract

PURPOSE:

Migraine is associated with vascular disorders, but the underlying mechanism is unknown. Nitric oxide (NO) sensitivity is believed to play a major role in migraine pathophysiology. We investigated flow-mediated vasodilatation (FMD) and nitroglycerin-mediated vasodilatation (NMD) of the brachial artery by means of a key molecular mediator, NO, in patients with migraine without aura in the interictal period whether the abnormality is found.

METHODS:

A total of 12 patients with migraine without aura and 12 matched healthy controls were enrolled in this study. FMD and NMD were measured in all patients and controls using brachial artery ultrasonography.

RESULTS:

There was no significant difference in brachial artery diameter between migraineurs and nonmigraineurs (3.39 ± 0.68 vs 3.89 ± 0.67 mm, respectively; p = 0.083). A significant difference in FMD was not found between migraineurs and nonmigraineurs (6.94 ± 5.72 vs 6.08 ± 2.98%, respectively; p = 0.651). However, NMD in migraineurs was significant higher than that in nonmigraineurs (21.56 ± 7.36 vs 14.23 ± 7.41%, respectively; p = 0.024).

CONCLUSION:

We think that patients with migraine without aura in the interictal period have selective sensitivity in dilator response to nitroglycerin and may have systemic NO sensitivity.

KEYWORDS:

Flow-mediated vasodilation; Migraine headache; NO sensitivity; Nitroglycerin; Nitroglycerin-mediated vasodilation

PMID:
29796732
PMCID:
PMC6339883
DOI:
10.1007/s10396-018-0880-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center